Try Alerts Free   |   Login
Consumer Staples › Canned, Fruits, Veg And Preserves, Jams And Jellies

LFCR Price Correlated With Financials For Lifecore Biomedical

Free historical financial statements for Lifecore Biomedical. See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2011. Compare with LFCR stock chart to see long term trends.

LFCR Stock Compared to Quarterly

LFCR Income Statement

Revenue, Net:43355000
Revenue Per Share:1.4649
Cost of Goods & Services Sold:37534000
Gross Profit:5821000
Selling, General & Admin Expense:10883000
Research & Development Expense:2048000
Total Operating Expenses:13978000
Operating Income:-12000000
Income Taxes:64000
Net Income:-12064000
Earnings Per Share, Basic:-0.41
Shares Outstanding, Basic Avg:29595554

LFCR Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:5009000
Net Cash from Operations:-1533000
Net Cash from Operations Per Share:-0.0518
Net Cash from Financing Activities:3906000
Property, Plant & Equipment Purchases:2929000
Net Cash from Investing Activities:206000
Net Change in Cash & Equivalents:2579000

LFCR Balance Sheet

Cash and Cash Equivalents:4222000
Accounts Receivable, Net:40934000
Inventories:64285000
Total Current Assets:116598000
Property, Plant & Equipment, Net:129024000
Total Assets:285800000
Accounts Payable:16366000
Current Portion of Long-Term Debt:2704000
Total Short-Term Liabilities:83099000
Long Term Debt, Non-Current Portion:95865000
Total Liabilities:188901000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I   10% Owner
103,000 sh at $8
$833,270
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Wynnefield Capital Inc
3,533,287 sh
 
$31,411
Legion Partners Asset Management, LLC
2,940,340 sh
 
$26,140
Cove Street Capital, LLC
1,888,494 sh
-32,927 sh
-2%
$16,788
-$2,369
Dimensional Fund Advisors LP
1,833,902 sh
-97,706 sh
-5%
$16,304
-$2,954
Blackrock Inc.
1,807,246 sh
-94,776 sh
-5%
$16,067
-$2,895
22NW, Lp
1,755,161 sh
531,251 sh
43%
$15,603
$1,430
Iszo Capital Management Lp
1,530,652 sh
-710,742 sh
-32%
$13,607
-$8,740
Vanguard Group Inc
1,268,099 sh
-3,488 sh
0%
$11,273
-$1,405
Heartland Advisors Inc
1,208,850 sh
-4,500 sh
0%
$10,747
-$1,350
Punch & Associates Investment Management, Inc.
723,200 sh
332,165 sh
85%
$6,429
$2,530
Morgan Stanley
615,037 sh
6,246 sh
1%
$5,466
-$604
Tocqueville Asset Management L.P.
602,900 sh
-5,550 sh
-1%
$5,360
-$706
Visionary Wealth Advisors
524,489 sh
5,953 sh
1%
$4,663
-$1,342
State Street Corp
498,057 sh
777 sh
0%
$4,428
-$530
Pacific Ridge Capital Partners, LLC
485,770 sh
-12,242 sh
-2%
$4,318
-$647
Geode Capital Management, LLC
464,646 sh
-13,784 sh
-3%
$4,130
-$639
Russell Investments Group, Ltd.
291,770 sh
-5,178 sh
-2%
$2,593
-$366
Northern Trust Corp
227,760 sh
-6,282 sh
-3%
$2,025
-$685
Parkman Healthcare Partners LLC
202,248 sh
80,630 sh
66%
$1,798
$585
Point72 Asset Management, L.P.
186,204 sh
-17,496 sh
-9%
$1,655
-$376

Data imported from Lifecore Biomedical SEC filings. Check original filings before making any investment decision.